Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Japanese parent to close UK fibreglass factory

(Sharecast News) - The UK's largest fibreglass factory is to close, its Japanese parent announced on Wednesday, after it failed to secure a buyer. In a brief regulatory announcement, Nippon Electric Glass Co confirmed it would cease operations at the Wigan plant, with production slated to stop by the end of this month. It will then enter into voluntary liquidation.

The UK business, Electric Glass Fiber UK, employs around 250 people and supplies fibreglass for use in electric cars and wind turbines. However, losses have ballooned while sales have steadily fallen.

Losses were £12m in the year to December end, on net sales of £54m. In 2023, sales came in at £56m while losses were just £3m.

It is understood the government tried and failed to secure a rescue deal for the plant.

According to the Financial Times, a London-based investment start-up called Tegu had held discussions about buying the plant but wanted the government to underwrite £5m of financing, which ministers declined.

The FT also noted that another private equity bidder had made a £10m offer but had been put off by Nippon's £2m break fee.

Nippon Electric Glass first warned in April that, following a strategic review, it planned to close the factory if a deal was not agreed within two months.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.